Oculis Holding AG (OCS) Interest Expenses (2022 - 2026)
Quarterly Interest Expenses rose 19.58% to -$220921.8 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$203.3 million through Mar 2026, up 33.44% year-over-year, with the annual reading at -$1.0 million for FY2025, 42.88% down from the prior year.
Oculis Holding AG's Interest Expenses history spans 5 years, with the latest figure at -$220921.8 for Q1 2026.
- Interest Expenses came in at -$220921.8 for Q1 2026, up from -$301531.9 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of -$12453.7 in Q3 2023 to a low of -$304.7 million in Q3 2024.
- The 5-year median for Interest Expenses is -$278340.9 (2025), against an average of -$32.2 million.
- Year-over-year, Interest Expenses skyrocketed 99.34% in 2023 and then tumbled 2446652.74% in 2024.
- Oculis Holding AG's Interest Expenses stood at -$1.4 million in 2022, then skyrocketed by 99.01% to -$13528.3 in 2023, then plummeted by 1984.2% to -$281955.9 in 2024, then dropped by 6.94% to -$301531.9 in 2025, then grew by 26.73% to -$220921.8 in 2026.
- Per Business Quant, the three most recent readings for OCS's Interest Expenses are -$220921.8 (Q1 2026), -$301531.9 (Q4 2025), and -$202.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 12.90 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -332,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Oculis Holding AG | 24.51 Bn | 24.21 Bn | - | -220,921.81 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -220,921.81 |
| Mar 31, 2026 | -220,921.81 |
| Dec 31, 2025 | -301,531.92 |
| Dec 31, 2025 | -301,531.92 |
| Sep 30, 2025 | -202.52 Mn |
| Sep 30, 2025 | -202.52 Mn |
| Jun 30, 2025 | -221,043.91 |
| Jun 30, 2025 | -221,043.91 |
| Mar 31, 2025 | -274,725.88 |
| Mar 31, 2025 | -274,725.88 |
| Dec 31, 2024 | -281,955.90 |
| Dec 31, 2024 | -281,955.90 |
| Sep 30, 2024 | -304.71 Mn |
| Sep 30, 2024 | -304.71 Mn |
| Jun 30, 2024 | -96,204.03 |
| Jun 30, 2024 | -96,204.03 |
| Mar 31, 2024 | -46,972.97 |
| Mar 31, 2024 | -46,972.97 |
| Dec 31, 2023 | -13,528.25 |
| Dec 31, 2023 | -13,528.25 |
| Sep 30, 2023 | -12,453.68 |
| Sep 30, 2023 | -12,453.68 |
| Jun 30, 2023 | -18,906.98 |
| Jun 30, 2023 | -18,906.98 |
| Mar 31, 2023 | -1.38 Mn |
| Mar 31, 2023 | -1.38 Mn |
| Dec 31, 2022 | -1.37 Mn |
| Dec 31, 2022 | -1.37 Mn |
| Sep 30, 2022 | -1.90 Mn |
| Sep 30, 2022 | -1.90 Mn |
| Jun 30, 2022 | -1.73 Mn |
| Jun 30, 2022 | -1.73 Mn |